Riktkurs.nu
EN | SV
Stockholm Stock Exchange
Bonesupport
+83.62% (177.60)
+58.90% (125.10)
DNB CarnegieSEBNordeaCarnegieSEB EquitiesABG Sundal Collier

Latest Target

+83.62%
390.00 SEK

Three Month Consensus

+58.90%
337.50 SEK

All Price Targets For Bonesupport

DNB Carnegie
390.00 SEK
+83.62%
SEB
SEB
Apr 23
285.00 SEK
+34.18%
Nordea
Nordea
Sep -25
370.00 SEK
+74.20%
Carnegie
Carnegie
Jan -25
450.00 SEK
+111.86%
SEB Equities
332.00 SEK
+56.31%
ABG Sundal Collier
310.00 SEK
+45.95%

About The Company

Bonesupport Holding AB is a Swedish pharmaceutical company that develops and markets the synthetic injectable bone graft substitute Cerament, which is used in the treatment of skeletal injuries. Bonesupport was founded in the early 2000s as a research company in Lund by orthopedist Lars Lidgren.
Wikipedia